

[ Tue, May 07th 2019
] - WOPRAI
[ Tue, May 07th 2019
] - WOPRAI
[ Tue, May 07th 2019
] - WOPRAI
[ Tue, May 07th 2019
] - WOPRAI
[ Tue, May 07th 2019
] - WOPRAI
[ Tue, May 07th 2019
] - WOPRAI

[ Mon, May 06th 2019
] - WOPRAI
[ Mon, May 06th 2019
] - WOPRAI
[ Mon, May 06th 2019
] - WOPRAI
[ Mon, May 06th 2019
] - WOPRAI
[ Mon, May 06th 2019
] - WOPRAI
[ Mon, May 06th 2019
] - WOPRAI
[ Mon, May 06th 2019
] - WOPRAI
[ Mon, May 06th 2019
] - WOPRAI
[ Mon, May 06th 2019
] - WOPRAI
[ Mon, May 06th 2019
] - WOPRAI
[ Mon, May 06th 2019
] - WOPRAI
Thomas Smith Initiated (ACRS) at Buy on, May 6th, 2019
Thomas Smith of SVB Leerink, Initiated "Aclaris Therapeutics, Inc." (ACRS) at Buy on, May 6th, 2019.
Thomas, nor any peers, have made any analyst calls on ACRS in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources